Sign In
Buy KLRS
Kalaris Therapeutics Stock Insider Power
Based on the 82 latest insides trades, we have calculated the insider power to be positive at 99.75. In total, the insiders bought 30.19M and sold 70.64K KLRS shares in the last 82 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
99.75 |
| ● Buy | 30.19M shares |
| ● Sell | 70.64K shares |
|
95% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Apr 10, 2025 Buy |
Oxtoby Andrew See Remarks |
287 000 Value: $2.10M |
||
|
Apr 10, 2025 Buy |
Adamis Anthony P Director |
18 000 Value: $131.6K |
||
|
Apr 10, 2025 Buy |
Feinsod Matthew Chief Medical Officer |
101 000 Value: $738.3K |
||
|
Apr 10, 2025 Buy |
Feinsod Matthew Chief Medical Officer |
70 551 Value: $515.7K |
||
|
Apr 10, 2025 Buy |
Patterson Leone D Director |
18 000 Value: $131.6K |
||
|
Apr 10, 2025 Buy |
Hagen Brett R Chief Accounting Officer |
50 262 Value: $367.4K |
||
|
Apr 10, 2025 Buy |
Akkaraju Srinivas |
18 000 Value: $131.6K |
||
|
Apr 10, 2025 Buy |
Jovan-embiricos Morana Director |
18 000 Value: $131.6K |
||
|
Apr 10, 2025 Buy |
Patel Samir Chandrakant Director |
18 000 Value: $131.6K |
||
|
Apr 10, 2025 Buy |
Ferrara Napoleone Director |
18 000 Value: $131.6K |
||
|
Apr 10, 2025 Buy |
Oxtoby Andrew See Remarks |
287 000 Value: $2.10M |
||
|
Apr 10, 2025 Buy |
Adamis Anthony P Director |
18 000 Value: $131.6K |
||
|
Apr 10, 2025 Buy |
Feinsod Matthew Chief Medical Officer |
101 000 Value: $738.3K |
||
|
Apr 10, 2025 Buy |
Feinsod Matthew Chief Medical Officer |
70 551 Value: $515.7K |
||
|
Apr 10, 2025 Buy |
Patterson Leone D Director |
18 000 Value: $131.6K |
||
|
Apr 03, 2025 Buy |
Patterson Leone D Insider |
0 Value: $0 |
||
|
Apr 03, 2025 Buy |
Patterson Leone D Insider |
0 Value: $0 |
||
|
Mar 26, 2025 Sell |
Hagen Brett R Chief Accounting Officer |
907 Value: $8K |
||
|
Mar 26, 2025 Sell |
Hagen Brett R Chief Accounting Officer |
907 Value: $8K |
||
|
Mar 18, 2025 Buy |
Akkaraju Srinivas |
0 Value: $0 |
||
|
Mar 18, 2025 Buy |
Akkaraju Srinivas |
0 Value: $0 |
||
|
Mar 18, 2025 Buy |
Samsara Biocapital Gp, Llc 10 Percent Owner |
0 Value: $0 |
||
|
Mar 18, 2025 Buy |
Samsara Biocapital Gp, Llc 10 Percent Owner |
0 Value: $0 |
||
|
Mar 18, 2025 Buy |
Patel Samir Chandrakant Director |
100 800 Value: $988.8K |
||
|
Mar 18, 2025 Buy |
Feinsod Matthew Chief Medical Officer |
28 224 Value: $24.0K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
